The painful impact of CMV

Approximately 50% of transplant patients develop symptomatic CMV infection in the first 12 months, despite anti-viral prophylaxis.

CMV disease can add ~40% to the cost of a solid organ transplant.

Typical solid organ transplant costs US$200–700K depending on organ and relative health of the recipient.

The gift of life is precious -- transplant patients need our help

Despite continued improvement in transplantation, CMV infection remains one of the leading causes of posttransplant morbidity and mortality

CMV viral load testing is critical to protect transplant patients

CMV viral load testing is routinely performed in a posttransplant setting to protect patients from CMV disease.

CMV DNA detection by PCR to monitor CMV viral load is:
-- The current standard in many transplant centers
-- Highly sensitive and rapid
-- Standardized against internationally accepted reference cut-offs